Home
Brain tumour immunology and therapy group
News

New paper in British Journal of Cancer

Our new paper "Bortezomib administered prior to temozolomide depletes MGMT, chemosensitizes glioblastoma with unmethylated MGMT promoter and prolongs animal survival" has been published in British Journal of Cancer.

Heading of journal
Photo:
Martha C Enger et al

Main content

Click the link to read the paper

https://rdcu.be/bORMR